Roland G. Staal, Ph.D.
Affiliations: | 2000 | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
Neuroscience Biology, Pharmacology, ToxicologyGoogle:
"Roland Staal"Mean distance: 42746.4
Parents
Sign in to add mentor| Patricia K. Sonsalla | grad student | 2000 | Rutgers, New Brunswick | |
| (The role of the vesicular monoamine transporter 2 (VMAT2) in neurotoxicity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen JF, Steyn S, Staal R, et al. (2002) 8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. The Journal of Biological Chemistry. 277: 36040-4 |
| Staal RG, Yang JM, Hait WN, et al. (2001) Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Research. 910: 116-25 |
| Chen J, Xu K, Petzer JP, et al. (2001) Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease The Journal of Neuroscience. 21: RC143-RC143 |
| Hogan KA, Staal RG, Sonsalla PK. (2000) Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations. Journal of Neurochemistry. 74: 2217-20 |
| Staal RG, Sonsalla PK. (2000) Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. The Journal of Pharmacology and Experimental Therapeutics. 293: 336-42 |
| Staal RG, Hogan KA, Liang CL, et al. (2000) In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. The Journal of Pharmacology and Experimental Therapeutics. 293: 329-35 |